Eli Lilly has unveiled a $27bn investment in US manufacturing facilities as the pharmaceutical industry prepares for the threat of tariffs and mounts a charm offensive aimed at President Donald ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback